Estimation of the Epidemiological Burden of Human Papillomavirus-related Cancers and Non-malignant Diseases in Men in Europe: a Review

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2012 Jan 21

PMID 22260541

Citations 73

Authors

Susanne Hartwig

Stina Syrjanen

Geraldine Dominiak-Felden

Maria Brotons

Xavier Castellsague

Affiliations

Soon will be listed here.

Abstract

Background: The role of human papillomavirus (HPV) in malignant and non-malignant genital diseases in women is well known and the corresponding epidemiological burden has been widely described. However, less is known about the role of HPV in anal, penile and head and neck cancer, and the burden of malignant and non-malignant HPV-related diseases in men. The objective of this review is to estimate the epidemiological burden of HPV-related cancers and non-malignant diseases in men in Europe.

Methods: The annual number of new HPV-related cancers in men in Europe was estimated using Eurostat population data and applying cancer incidence rates published by the International Agency for Research on Cancer. The number of cancer cases attributable to HPV, and specifically to HPV16/18, was calculated based on the most relevant prevalence estimates. The annual number of new cases of genital warts was calculated from the most robust European studies; and latest HPV6/11 prevalence estimates were then applied. A literature review was also performed to retrieve exhaustive data on HPV infection at all anatomical sites under study, as well as incidence and prevalence of external genital warts, recurrent respiratory papillomatosis and HPV-related cancer trends in men in Europe.

Results: A total of 72, 694 new cancer cases at HPV-related anatomical sites were estimated to occur each year in men in Europe. 17,403 of these cancer cases could be attributable to HPV, with 15,497 of them specifically attributable to HPV16/18. In addition, between 286,682 and 325,722 new cases of genital warts attributable to HPV6/11were estimated to occur annually in men in Europe.

Conclusions: The overall estimated epidemiological burden of HPV-related cancers and non-malignant diseases is high in men in Europe. Approximately 30% of all new cancer cases attributable to HPV16/18 that occur yearly in Europe were estimated to occur in men. As in women, the vast majority of HPV-positive cancer in men is related to HPV16/18, while almost all HPV-related non-malignant diseases are due to HPV6/11. A substantial number of these malignant and non-malignant diseases may potentially be prevented by quadrivalent HPV vaccination.

Citing Articles

The Potential Role of the Microbiome in the Pathogenesis of Nasal Tumors: A Comprehensive Review.

Loperfido A, Rizzo D, Fionda B, Mureddu L, Tondo A, Tagliaferri L Medicina (Kaunas). 2024; 60(11).

PMID: 39596994 PMC: 11596812. DOI: 10.3390/medicina60111808.

High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity.

Cabibi D, Giannone A, Quattrocchi A, Lo Coco R, Formisano E, Porcasi R Int J Mol Sci. 2024; 25(10).

PMID: 38791395 PMC: 11121605. DOI: 10.3390/ijms25105354.

The Burden of HPV-Related Hospitalizations: Analysis of Hospital Discharge Records from the Years 2015-2021 from a Southern Italian Region.

Di Martino G, Cedrone F, Di Giovanni P, Tognaccini L, Trebbi E, Romano F Pathogens. 2023; 12(5).

PMID: 37242395 PMC: 10220951. DOI: 10.3390/pathogens12050725.

Metastasis to the penis from a bladder carcinoma invading only the lamina propria: case report and description of the morphological aspects.

Stanimir M, Lorge F, DHondt L, Nollevaux M, Di Gregorio M Rom J Morphol Embryol. 2023; 64(1):89-94.

PMID: 37128796 PMC: 10257781. DOI: 10.47162/RJME.64.1.11.

Tracking HPV Infection, Associated Cancer Development, and Recent Treatment Efforts-A Comprehensive Review.

Malik S, Sah R, Muhammad K, Waheed Y Vaccines (Basel). 2023; 11(1).

PMID: 36679945 PMC: 9860736. DOI: 10.3390/vaccines11010102.

References

Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G . Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009; 125(2):362-6. DOI: 10.1002/ijc.24339. View

Kataoka A, CLAESSON U, Hansson B, Eriksson M, Lindh E . Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol. 1991; 33(3):159-64. DOI: 10.1002/jmv.1890330304. View

Eike A, Buchwald C, Rolighed J, Lindeberg H . Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol Allied Sci. 1995; 20(2):171-3. DOI: 10.1111/j.1365-2273.1995.tb00038.x. View

van der Snoek E, Niesters H, Mulder P, van Doornum G, Osterhaus A, van der Meijden W . Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis. 2003; 30(8):639-44. DOI: 10.1097/01.OLQ.0000079520.04451.59. View

Aynaud O, Ionesco M, Barrasso R . Cytologic detection of human papillomavirus DNA in normal male urethral samples. Urology. 2003; 61(6):1098-101. DOI: 10.1016/s0090-4295(03)00110-9. View

Kjaer S, Tran T, Sparen P, Tryggvadottir L, Munk C, Dasbach E . The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007; 196(10):1447-54. DOI: 10.1086/522863. View

Kreimer A, Clifford G, Boyle P, Franceschi S . Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2):467-75. DOI: 10.1158/1055-9965.EPI-04-0551. View

Giovannelli L, Migliore M, Capra G, Caleca M, Bellavia C, Perino A . Penile, urethral, and seminal sampling for diagnosis of human papillomavirus infection in men. J Clin Microbiol. 2006; 45(1):248-51. PMC: 1828977. DOI: 10.1128/JCM.01576-06. View

Forslund O, Hansson B, Rymark P, Bjerre B . Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol. 1993; 31(8):1975-9. PMC: 265682. DOI: 10.1128/jcm.31.8.1975-1979.1993. View

10.

. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2008; 90:1-636. PMC: 4781057. View

11.

Barzon L, Militello V, Pagni S, Franchin E, Dal Bello F, Mengoli C . Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol. 2010; 82(8):1424-30. DOI: 10.1002/jmv.21733. View

12.

Miralles-Guri C, Bruni L, Cubilla A, Castellsague X, Bosch F, de Sanjose S . Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009; 62(10):870-8. DOI: 10.1136/jcp.2008.063149. View

13.

Kjaer S, Breugelmans G, Munk C, Junge J, Watson M, Iftner T . Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer. 2008; 123(8):1864-70. DOI: 10.1002/ijc.23712. View

14.

Menton J, Cremin S, Canier L, Horgan M, Fanning L . Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland. Virol J. 2009; 6:112. PMC: 2724505. DOI: 10.1186/1743-422X-6-112. View

15.

Syrjanen S . HPV infections and tonsillar carcinoma. J Clin Pathol. 2004; 57(5):449-55. PMC: 1770289. DOI: 10.1136/jcp.2003.008656. View

16.

Backes D, Kurman R, Pimenta J, Smith J . Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2008; 20(4):449-57. DOI: 10.1007/s10552-008-9276-9. View

17.

Giuliano A, Lazcano-Ponce E, Villa L, Flores R, Salmeron J, Lee J . The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):2036-43. PMC: 3471778. DOI: 10.1158/1055-9965.EPI-08-0151. View

18.

Bleeker M, Hogewoning C, Voorhorst F, van den Brule A, Berkhof J, Hesselink A . HPV-associated flat penile lesions in men of a non-STD hospital population: less frequent and smaller in size than in male sexual partners of women with CIN. Int J Cancer. 2004; 113(1):36-41. DOI: 10.1002/ijc.20502. View

19.

Hobbs C, Sterne J, Bailey M, Heyderman R, Birchall M, Thomas S . Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006; 31(4):259-66. DOI: 10.1111/j.1749-4486.2006.01246.x. View

20.

Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J . The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol. 2007; 127(9):988-92. DOI: 10.1080/00016480601110170. View